Compare Arqit Quantum Inc (ARQQ) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arqit Quantum Inc vs TG Therapeutics Inc — how do they compare? Arqit Quantum Inc trades at $17.99 (market cap $332.04M), while TG Therapeutics Inc trades at $55.47 (market cap $8.74B). The key difference: TG Therapeutics Inc is far larger — about 26.3× Arqit Quantum Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.
| ARQQ | TGTX | |
|---|---|---|
Market Cap | $332.04M | $8.74B |
Sector | Technology | Health |
52-Week High | $58.27 | $59.06 |
52-Week Low | $11.78 | $26.39 |
Enterprise Value | $305.35M | $8.98B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Arqit Quantum Inc
Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
